Orchestra

What Orchestra does

Orchestra Bio Inc. is a private, San Francisco-based software company that builds an agentic operations platform for drug development R&D. The platform serves biotech and life sciences companies — from early-stage startups through large pharmaceutical organizations — that need to manage the operational complexity of scientific programs, financial planning, and cross-functional execution. The company's stated mission is to reduce the operational complexity of developing medicines by aligning teams from bench to boardroom.

The product is organized into three interconnected modules. Unified Planning provides a centralized roadmap builder that aligns scientific goals, budgets, hiring, and scenarios into a single source of truth and is positioned to compress board-meeting preparation from weeks to days. Intelligent Operations uses AI to interpret meetings, documents, and reports to track progress, surface risks, and detect delays against plan. Decision Support offers scenario modeling across programs and budgets alongside an AI-powered knowledge base that leverages institutional context. Underlying these modules is an agentic AI architecture in which agents operate in closed loops, autonomously breaking goals into executable steps, connecting to databases and APIs, synthesizing information, and self-reviewing before presenting recommendations.

Orchestra generates revenue through SaaS subscriptions to its enterprise platform, with pricing not publicly disclosed and delivered through a product-led growth motion anchored by a 'Book a demo' consultative sales process. The company exited stealth in 2025 with $20 million in funding, operates with a 1–10 person team of engineers, operators, and scientists with biotech and AI backgrounds, and is led by CEO Ashoka Rajendra and CTO Andy Xu.

Name

Orchestra

Legal name

Orchestra Bio Inc.

Website

https://orchestra.bio

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Orchestra Bio Inc. is a San Francisco-based software company that provides an agentic AI operations platform — spanning planning, operations tracking, and decision support — to biotech and life sciences companies managing drug development R&D.

Ownership category

akta.pro rank

Product category

Biotech R&D Operations Software

NAICS

Management, Scientific, and Technical Consulting Services (5416)

akta.pro primary industry

Digital Process Automation (DPA) & Orchestration Suites (HDAEAHAF)

Keywords

• R&D operations platform
• Drug development software
• Biotech planning software
• Scientific portfolio management
• Life sciences AI

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. SaaS Platform Subscription: Software-as-a-service platform for biotech R&D operations. Based on enterprise software pricing patterns and product-led growth motion, likely offers subscription-based pricing with tiered plans based on team size or feature access.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Orchestra is the agentic operations platform for drug development R&D, unifying scientific, operational, and financial context into a single intelligent environment for biotech and life sciences companies. It delivers three core modules — Unified Planning, Intelligent Operations, and Decision Support — that combine AI-powered progress tracking, scenario modeling, and an institutional knowledge base to align R&D teams from bench to boardroom.

Product overview

Orchestra is an agentic operations platform for drug development, built as a unified platform with three interconnected modules: Unified Planning (for aligning scientific goals, financial models, and execution into one operating plan), Intelligent Operations (for automatically tracking progress, risks, and outcomes from day-to-day execution), and Decision Support (for scenario modelling and leveraging AI-powered knowledge bases to drive decisions). The platform acts as both a system of record and a system of intelligence, interpreting data so teams can operate with speed, evidence, and alignment from bench to boardroom.

Differentiator

Problem solved

Functional benefit

Products and services

• Unified Planning Centralized planning module for biotech and life sciences R&D teams that aligns scientific roadmaps, budgets, hiring, and scenarios into one source of truth. Enables R&D planning with centralized roadmaps across leadership, programs, and scientific groups, financial modeling and spend forecasting across R&D, G&A, operations, and personnel, and translation of strategy into concrete roadmaps with clear dependencies and milestones. Allows board meeting preparation in days rather than weeks.
• Intelligent Operations Operations tracking module that automatically tracks progress, risks, and outcomes from day-to-day R&D execution. Uses AI-powered progress and risk tracking that interprets meetings, documents, and reports to determine true program state, tracks execution against plans in a single view, and surfaces delay and risk signals early. Built for biotech R&D operations teams needing continuous program visibility.
• Decision Support Decision support module combining a scenario builder with an AI-powered knowledge base for biotech R&D leaders. Enables combinatorial assessment of scenarios across programs and budgets, rapid evaluation of program delays, budget cuts, or accelerated timelines, and leverages institutional knowledge to drive decisions. Designed to give R&D leaders confident decision-making grounded in organizational context.

Quantifiable outcome

• Board meeting preparation reduced from weeks to days
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Dotmatics: Scientific informatics platform (now part of Siemens) covering ELN, LIMS, and discovery workflows for life sciences. Overlaps with Orchestra on serving biotech R&D teams with planning and data infrastructure, though without the agentic decision-support angle.
• IQVIA: Global life sciences technology and services provider with R&D, clinical, and commercial platforms. Comparable as a broad incumbent touching biotech R&D operations, though Orchestra targets a far more focused agentic niche within that ecosystem.
• Veeva Systems: Large incumbent cloud software provider for life sciences with Vault R&D and clinical suites. Comparable as a broad enterprise platform selling into biotech/pharma R&D, but serves a much wider portfolio and is not specialized in agentic operational orchestration.
• LabVantage: Established LIMS and lab informatics vendor serving life sciences R&D and QA/QC. Comparable in selling workflow/operations software to biotech enterprises, but with a legacy on-prem orientation rather than an agentic AI architecture.

Direct peers

• Benchling: Leading cloud R&D platform for biotech that spans experimental data, molecular biology, and registry workflows. Most direct comparable to Orchestra in serving biotech R&D teams with a unified software platform, though Benchling focuses more on the wet-lab data layer than operational/financial orchestration.

Emerging players

• Scientist.com: Marketplace and workflow platform for outsourced biotech R&D services. Comparable as a digital operations layer for life sciences R&D, though focused on procurement rather than internal planning and decision support.
• TetraScience: R&D data cloud and AI platform for life sciences that ingests lab instrument and operational data. Comparable as an emerging data/AI infrastructure layer for biotech R&D and a likely partner-or-competitor for Orchestra's Intelligent Operations module.
• Ganymede: Developer of a cloud-native lab data platform with focus on biotech and life sciences. Comparable as an emerging player targeting the same R&D operations buyer with a more data-infrastructure orientation than Orchestra's planning/decision-support focus.
• Certis Oncology Solutions: Emerging biotech-focused services and software player. Listed as a partial-overlap emerging peer in the life sciences R&D operations space; overlap with Orchestra is thematically adjacent rather than direct product competition.
• Arctoris: Biotech R&D platform combining wet-lab automation with data and analytics. Comparable as an emerging digital/AI-enabled R&D operations player serving biotech, with partial overlap in the AI-for-R&D thesis Orchestra pursues.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/orchestrabio

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orchestra